Treatment of Adolescent Anorexia Nervosa (VISAN)

April 30, 2026 updated by: Region Örebro County

VISAN - vårdkedja i Samverkan för Unga Patienter Med Anorexia Nervosa (Collaborative Chain of Care in Adolescnt Anorexia Nervosa Treatment)

VISAN is a naturalistic study of family based treatment of Anorexia nervosa in adolescnet girls.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Having been diagnosed with f500 or f501 and being planned for family based therapy at the unit.

Exclusion Criteria:

  • being subjected to care by the social welfare system

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Family based treatment
Family based treatment including the whole chain of care, such as day care and in patiant care when necessary. The interventions includes consultation with dietician, psyciotherapist, LEAP-Y and Skills training based on an individual plan.
Family based therapy following the Maudsley model

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Remission
Time Frame: End of treatment (assessed up to 1 year)
No longer fulfilling criteria for an eating disorder
End of treatment (assessed up to 1 year)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2024

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2029

Study Registration Dates

First Submitted

November 25, 2024

First Submitted That Met QC Criteria

November 28, 2024

First Posted (Actual)

December 2, 2024

Study Record Updates

Last Update Posted (Actual)

May 1, 2026

Last Update Submitted That Met QC Criteria

April 30, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe